{
  "id": 20744478,
  "title": "Guggenheim raises MSG Rangers stock price target on valuation gap",
  "url": "https://urgent.news/2026/11/19/guggenheim-raises-msg-rangers-stock-price-target-on-valuation-gap",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-19T12:12:59.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/guggenheim-raises-msg-rangers-stock-price-target-on-valuation-gap-93CH-5038659"
  },
  "original_language": "en",
  "account": "Guggenheim raised its price target on MSG Rangers stock to $299 from $278 on Tuesday, maintaining a Buy rating. The company's stock is currently trading at $247.84, having surged 7.7% over the past week and nearing its 52-week high of $255. Guggenheim's updated model was based on the company's fiscal 2027 first-quarter earnings. Despite not hosting an earnings call due to the timing of the quarter, Guggenheim believes the Rangers have a significant discount between its net asset value and intrinsic value. Valuations from Sportico and Forbes were cited at $3.65 billion and $4.0 billion, respectively, while the Rangers' market cap is just $2.99 billion. The stock trades near its 52-week high with an EXCELLENT financial health score, and BTIG has adjusted its price target to $313, citing a valuation gap and increased investor interest following the Rangers' spin-off from Madison Square Garden Knickerbockers.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}